Index
1 Market Overview
1.1 Product Overview and Scope of Biomarker Analysis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biomarker Analysis by Type
1.3.1 Overview: Global Biomarker Analysis Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biomarker Analysis Consumption Value Market Share by Type in 2022
1.3.3 Diagnostic Biomarkers
1.3.4 Prognostic Biomarkers
1.3.5 Predictive Biomarkers
1.3.6 Safety Biomarkers
1.3.7 Surrogate Biomarkers
1.4 Global Biomarker Analysis Market by Application
1.4.1 Overview: Global Biomarker Analysis Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnosis
1.4.3 Prognosis
1.4.4 Treatment Selection
1.4.5 Monitoring
1.4.6 Clinical Trials
1.5 Global Biomarker Analysis Market Size & Forecast
1.6 Global Biomarker Analysis Market Size and Forecast by Region
1.6.1 Global Biomarker Analysis Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biomarker Analysis Market Size by Region, (2018-2029)
1.6.3 North America Biomarker Analysis Market Size and Prospect (2018-2029)
1.6.4 Europe Biomarker Analysis Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biomarker Analysis Market Size and Prospect (2018-2029)
1.6.6 South America Biomarker Analysis Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biomarker Analysis Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Bio-Rad
2.1.1 Bio-Rad Details
2.1.2 Bio-Rad Major Business
2.1.3 Bio-Rad Biomarker Analysis Product and Solutions
2.1.4 Bio-Rad Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bio-Rad Recent Developments and Future Plans
2.2 Eurofins Scientific
2.2.1 Eurofins Scientific Details
2.2.2 Eurofins Scientific Major Business
2.2.3 Eurofins Scientific Biomarker Analysis Product and Solutions
2.2.4 Eurofins Scientific Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eurofins Scientific Recent Developments and Future Plans
2.3 Crown Bioscience
2.3.1 Crown Bioscience Details
2.3.2 Crown Bioscience Major Business
2.3.3 Crown Bioscience Biomarker Analysis Product and Solutions
2.3.4 Crown Bioscience Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Crown Bioscience Recent Developments and Future Plans
2.4 Meridian Bioscience
2.4.1 Meridian Bioscience Details
2.4.2 Meridian Bioscience Major Business
2.4.3 Meridian Bioscience Biomarker Analysis Product and Solutions
2.4.4 Meridian Bioscience Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Meridian Bioscience Recent Developments and Future Plans
2.5 Thermo Fisher Scientific Inc.
2.5.1 Thermo Fisher Scientific Inc. Details
2.5.2 Thermo Fisher Scientific Inc. Major Business
2.5.3 Thermo Fisher Scientific Inc. Biomarker Analysis Product and Solutions
2.5.4 Thermo Fisher Scientific Inc. Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.6 Siemens Healthineers
2.6.1 Siemens Healthineers Details
2.6.2 Siemens Healthineers Major Business
2.6.3 Siemens Healthineers Biomarker Analysis Product and Solutions
2.6.4 Siemens Healthineers Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Siemens Healthineers Recent Developments and Future Plans
2.7 Roche Molecular Diagnostics
2.7.1 Roche Molecular Diagnostics Details
2.7.2 Roche Molecular Diagnostics Major Business
2.7.3 Roche Molecular Diagnostics Biomarker Analysis Product and Solutions
2.7.4 Roche Molecular Diagnostics Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Roche Molecular Diagnostics Recent Developments and Future Plans
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business
2.8.3 Abbott Laboratories Biomarker Analysis Product and Solutions
2.8.4 Abbott Laboratories Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Abbott Laboratories Recent Developments and Future Plans
2.9 Agilent/Dako
2.9.1 Agilent/Dako Details
2.9.2 Agilent/Dako Major Business
2.9.3 Agilent/Dako Biomarker Analysis Product and Solutions
2.9.4 Agilent/Dako Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Agilent/Dako Recent Developments and Future Plans
2.10 Becton, Dickinson and Company
2.10.1 Becton, Dickinson and Company Details
2.10.2 Becton, Dickinson and Company Major Business
2.10.3 Becton, Dickinson and Company Biomarker Analysis Product and Solutions
2.10.4 Becton, Dickinson and Company Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Becton, Dickinson and Company Recent Developments and Future Plans
2.11 Eve Technologies
2.11.1 Eve Technologies Details
2.11.2 Eve Technologies Major Business
2.11.3 Eve Technologies Biomarker Analysis Product and Solutions
2.11.4 Eve Technologies Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Eve Technologies Recent Developments and Future Plans
2.12 Fluidic Analytics
2.12.1 Fluidic Analytics Details
2.12.2 Fluidic Analytics Major Business
2.12.3 Fluidic Analytics Biomarker Analysis Product and Solutions
2.12.4 Fluidic Analytics Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Fluidic Analytics Recent Developments and Future Plans
2.13 Hybrigenics Services
2.13.1 Hybrigenics Services Details
2.13.2 Hybrigenics Services Major Business
2.13.3 Hybrigenics Services Biomarker Analysis Product and Solutions
2.13.4 Hybrigenics Services Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hybrigenics Services Recent Developments and Future Plans
2.14 Luminex Corp
2.14.1 Luminex Corp Details
2.14.2 Luminex Corp Major Business
2.14.3 Luminex Corp Biomarker Analysis Product and Solutions
2.14.4 Luminex Corp Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Luminex Corp Recent Developments and Future Plans
2.15 Qiagen
2.15.1 Qiagen Details
2.15.2 Qiagen Major Business
2.15.3 Qiagen Biomarker Analysis Product and Solutions
2.15.4 Qiagen Biomarker Analysis Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Qiagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biomarker Analysis Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biomarker Analysis by Company Revenue
3.2.2 Top 3 Biomarker Analysis Players Market Share in 2022
3.2.3 Top 6 Biomarker Analysis Players Market Share in 2022
3.3 Biomarker Analysis Market: Overall Company Footprint Analysis
3.3.1 Biomarker Analysis Market: Region Footprint
3.3.2 Biomarker Analysis Market: Company Product Type Footprint
3.3.3 Biomarker Analysis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Biomarker Analysis Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biomarker Analysis Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Biomarker Analysis Consumption Value Market Share by Application (2018-2023)
5.2 Global Biomarker Analysis Market Forecast by Application (2024-2029)
6 North America
6.1 North America Biomarker Analysis Consumption Value by Type (2018-2029)
6.2 North America Biomarker Analysis Consumption Value by Application (2018-2029)
6.3 North America Biomarker Analysis Market Size by Country
6.3.1 North America Biomarker Analysis Consumption Value by Country (2018-2029)
6.3.2 United States Biomarker Analysis Market Size and Forecast (2018-2029)
6.3.3 Canada Biomarker Analysis Market Size and Forecast (2018-2029)
6.3.4 Mexico Biomarker Analysis Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Biomarker Analysis Consumption Value by Type (2018-2029)
7.2 Europe Biomarker Analysis Consumption Value by Application (2018-2029)
7.3 Europe Biomarker Analysis Market Size by Country
7.3.1 Europe Biomarker Analysis Consumption Value by Country (2018-2029)
7.3.2 Germany Biomarker Analysis Market Size and Forecast (2018-2029)
7.3.3 France Biomarker Analysis Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biomarker Analysis Market Size and Forecast (2018-2029)
7.3.5 Russia Biomarker Analysis Market Size and Forecast (2018-2029)
7.3.6 Italy Biomarker Analysis Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Analysis Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biomarker Analysis Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biomarker Analysis Market Size by Region
8.3.1 Asia-Pacific Biomarker Analysis Consumption Value by Region (2018-2029)
8.3.2 China Biomarker Analysis Market Size and Forecast (2018-2029)
8.3.3 Japan Biomarker Analysis Market Size and Forecast (2018-2029)
8.3.4 South Korea Biomarker Analysis Market Size and Forecast (2018-2029)
8.3.5 India Biomarker Analysis Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biomarker Analysis Market Size and Forecast (2018-2029)
8.3.7 Australia Biomarker Analysis Market Size and Forecast (2018-2029)
9 South America
9.1 South America Biomarker Analysis Consumption Value by Type (2018-2029)
9.2 South America Biomarker Analysis Consumption Value by Application (2018-2029)
9.3 South America Biomarker Analysis Market Size by Country
9.3.1 South America Biomarker Analysis Consumption Value by Country (2018-2029)
9.3.2 Brazil Biomarker Analysis Market Size and Forecast (2018-2029)
9.3.3 Argentina Biomarker Analysis Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Analysis Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biomarker Analysis Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biomarker Analysis Market Size by Country
10.3.1 Middle East & Africa Biomarker Analysis Consumption Value by Country (2018-2029)
10.3.2 Turkey Biomarker Analysis Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biomarker Analysis Market Size and Forecast (2018-2029)
10.3.4 UAE Biomarker Analysis Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Biomarker Analysis Market Drivers
11.2 Biomarker Analysis Market Restraints
11.3 Biomarker Analysis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Biomarker Analysis Industry Chain
12.2 Biomarker Analysis Upstream Analysis
12.3 Biomarker Analysis Midstream Analysis
12.4 Biomarker Analysis Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer